Making sense of antimicrobial use and resistance surveillance data: application of ARIMA and transfer function models.
Monnet
D L
DL
Department of Microbiological Research and Development, Statens Serum Institut, Copenhagen, Denmark. dom@ssi.dk
López-Lozano
J M
JM
Campillos
P
P
Burgos
A
A
Yagüe
A
A
Gonzalo
N
N
D000583:Amikacin / Q000378:metabolism / Q000493:pharmacokinetics; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002442:Ceftazidime / Q000378:metabolism / Q000493:pharmacokinetics; D004352:Drug Resistance, Microbial; D005839:Gentamicins / Q000378:metabolism / Q000493:pharmacokinetics; D008962:Models, Theoretical; D011552:Pseudomonas Infections / Q000188:drug therapy; D011550:Pseudomonas aeruginosa / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D000583:Amikacin; D002442:Ceftazidime